Fortress Biotech (FBIO) Profit After Tax Growth (5y) (2015 - 2026)
Powered by 
Analysis
Fortress Biotech (FBIO) Profit After Tax Growth (5y) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.52 Bn | 133.66 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.69 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.63 Bn | 59.45 Bn | 1.37 Bn |
| 4 | Moderna | 59.30 Bn | 54.16 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.41 Bn | 44.41 Bn | - |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.29 Bn | 31.98 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - |
| 9 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn |
| 10 | Fortress Biotech | 86.15 Mn | -110.42 Mn | 12.58 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 15.15% |
| Dec 31, 2025 | 23.42% |
| Sep 30, 2025 | 18.07% |
| Jun 30, 2025 | 20.53% |
| Mar 31, 2025 | -0.51% |
| Dec 31, 2024 | 4.40% |
| Sep 30, 2024 | -1.34% |
| Jun 30, 2024 | -0.96% |
| Mar 31, 2024 | -19.14% |
| Dec 31, 2023 | -3.10% |
| Sep 30, 2023 | 17.81% |
| Jun 30, 2023 | -10.67% |
| Mar 31, 2023 | -7.61% |
| Dec 31, 2022 | -40.71% |
| Sep 30, 2022 | -14.37% |
| Jun 30, 2022 | -4.27% |
| Mar 31, 2022 | -8.24% |
| Dec 31, 2021 | -31.49% |
| Sep 30, 2021 | -28.71% |
| Jun 30, 2021 | -14.34% |